Clinical Trials Logo

Clinical Trial Summary

This study is to verify that Dermalax Implant Plus is not inferior to the reference device, Restylane® Sub-Q, in terms of efficacy and safety in the correction of nasolabial folds


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02179606
Study type Interventional
Source Across Co.,Ltd.
Contact
Status Completed
Phase Phase 3
Start date July 2013

See also
  Status Clinical Trial Phase
Completed NCT02334358 - Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s
Completed NCT03611491 - Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds N/A
Completed NCT05106751 - A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds Phase 4
Completed NCT02661737 - Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
Completed NCT03650218 - Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds N/A
Completed NCT05235126 - A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF) N/A
Completed NCT02179619 - Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds Phase 3
Unknown status NCT01492140 - Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers Phase 4